ACC slides: Cardiac troponin can measure risk in ischemic heart disease

9

description

SAN FRANCISCO—Serial measurements of cardiac troponin using an investigational high-sensitivity assay enhanced risk stratification for cardiovascular disease and heart failure in patients with stable ischemic heart disease, according to an analysis of the PROVE IT-TIMI 22 study, presented March 9 at the American College of Cardiology’s (ACC) scientific session.

Transcript of ACC slides: Cardiac troponin can measure risk in ischemic heart disease

Page 1: ACC slides: Cardiac troponin can measure risk in ischemic heart disease
Page 2: ACC slides: Cardiac troponin can measure risk in ischemic heart disease
Page 3: ACC slides: Cardiac troponin can measure risk in ischemic heart disease
Page 4: ACC slides: Cardiac troponin can measure risk in ischemic heart disease
Page 5: ACC slides: Cardiac troponin can measure risk in ischemic heart disease
Page 6: ACC slides: Cardiac troponin can measure risk in ischemic heart disease
Page 7: ACC slides: Cardiac troponin can measure risk in ischemic heart disease
Page 8: ACC slides: Cardiac troponin can measure risk in ischemic heart disease
Page 9: ACC slides: Cardiac troponin can measure risk in ischemic heart disease